Navigating Chaos: Jan Ramakers on Why the API Market Is Harder to Read Than Ever

About this episode

Jan Ramakers discusses the complexities and challenges of the API market amidst geopolitical and supply chain issues.

"If you feel the rules are changing every five minutes, that's not going to help you — because this is a long-term industry." Jan Ramakers is an independent consultant with over two decades of experience tracking the fine chemicals and pharmaceutical ingredients market. A chemist by training, Jan has worked across pharma, agrochemicals, and the financial sector, spanning market intelligence, competitor analysis, and M&A due diligence. In this PharmaSource podcast episode, Jan explains why the API outsourcing market is at an inflection point shaped by geopolitical uncertainty, supply chain fragility, and the evolving race among CDMOs to differentiate. Drawing on career-long pattern recognition, he outlines what is actually happening on the ground versus what the industry often gets wrong. Read more .

People in this episode

Guest: Jan Ramakers

Topics covered

• API market
• outsourcing
• geopolitical uncertainty
• supply chain
• CDMO differentiation

Keywords

• API market
• pharmaceutical ingredients
• outsourcing
• geopolitical uncertainty
• supply chain fragility
• CDMO

Mentioned in this episode

Organizations: PharmaSource, CDMO, Life Science Networks

More episodes of PharmaSource Podcast

• How Sanofi Navigates Regulatory CMC Across Global Markets: Insights from Manda Pasarkar · June 11, 2026 · 31 min
• The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma's Global Strategy · June 8, 2026 · 18 min
• How to Build a Resilient Global Vaccine Supply Chain: From Crisis to Capability · June 4, 2026 · 46 min
• How Lonza Is Outgrowing the CDMO Market with Bioconjugation, AI, and Regionalization · May 31, 2026 · 29 min
• The Strategic Partnership Gap: Why CDMOs Are Meeting Pharma's Expectations Less Than Half the Time with Simon-Kucher · May 27, 2026 · 26 min
• Creative Financing Strategies for Biotech's Bear Market, Beyond the VC Round · May 25, 2026 · 29 min